Stéphanie Doyle: Forvis Mazars is becoming a Grand Partner of Montréal InVivo today. What made you want to deepen your commitment to our life sciences and health technologies ...
Stéphanie Doyle: Montréal InVivo has just moved into Inspire BioInnovations, a new life sciences hub in Montreal initiated through CellCarta’s vision. In your o...
Stéphanie Doyle: You will soon celebrate your first anniversary as CEO of the CQDM (April 2025). What have been the main lessons from this experience so far? ...
Dear Ecosystem, The year 2025 was a pivotal one for Montréal InVivo and for the life sciences and health technologies ecosystem. It was marked in particular by a significant le...
Artificial Intelligence: An Analytical Tool with Immense Potential Stéphanie Doyle: Artificial intelligence generates a lot of uncertainty, but in research, its impact is alrea...
Stéphanie Doyle: Lately, there’s been a lot of talk about financing and access to capital in an uncertain economic context. How do you see this situation impacting life scien...
In a global context marked by political, economic, and scientific upheavals, researchers and academic institutions must constantly adapt. To explore these challenges, Stéphanie...
Three Months Already at Montréal InVivo Time is flying by! These past three months have been filled with learning opportunities, inspiring encounters, and unique occasions to h...
